IVERIC bio (ISEE) Misses Q4 EPS by 5c

IVERIC bio (NASDAQ: ISEE) reported Q4 EPS of ($0.29), $0.05 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on IVERIC bio (ISEE) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
• Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c